Summary of Privia Health's Q2 2026 Earnings Call

1Key Financial Results and Metrics

Implemented Providers: Grew to 5,644, a 10.1% year-over-year increase.

Practice Collections: Reached $970 million, up 12.4% from the previous year.

Adjusted EBITDA: Increased by 29% to $37.4 million, representing 28.3% of care margin, with a 310 basis point margin improvement.

First Half Performance: Practice collections rose 13.4% to $1.88 billion; adjusted EBITDA grew 32.5% to $74.1 million.

Cash Position: Ended the quarter with over $412 million in cash and no debt.

2Strategic Updates and Business Highlights

Market Expansion: Entered New Jersey with a partnership with the Urology Group of Bergen County, marking Privia's 25th state.

Provider Retention: Maintained a gross provider retention rate of 98% over the past three years.

Value-Based Care Growth: Attributed lives increased by 19.2% year-over-year, with significant growth in Medicare and Medicaid populations.

AI Integration: Continued deployment of AI applications across workflows to enhance efficiency and profitability.

3Forward Guidance and Outlook

2026 Outlook Raised: Increased guidance for practice collections, care margin, and EBITDA, with attributed lives exceeding previous expectations.

Implemented Provider Growth: Guidance remains unchanged, targeting an addition of 570 providers, reflecting a 10.6% growth over 2025.

Long-Term EBITDA Margin Target: Aiming for the high end of the 30%-35% range over the next few years, supported by operational efficiencies and AI initiatives.

4Bad News, Challenges, or Points of Concern

CMS Shared Savings Payment Delay: Potential delays in cash settlements from CMS could impact year-end cash flow dynamics, although management expressed confidence in receiving payments.

Implied Deceleration in Growth: Guidance suggests a slowdown in practice collections growth from 13% in the first half to about 3% in the second half, raising questions about potential headwinds or conservative forecasting.

Provider Expenses: Increased provider expenses outpaced revenue growth, which could affect margins if not managed effectively.

5Notable Q&A Insights

Confidence in CMS Payments: Management reassured that delays in CMS payments are not a major concern, citing a history of timely settlements.

AI Opportunities: Management highlighted ongoing AI initiatives aimed at improving efficiencies across various workflows, linking these efforts directly to EBITDA margin expansion.

Market Dynamics: The transition from ACO REACH to LEAD presents both challenges and opportunities for expansion, with management optimistic about capturing market share through strategic acquisitions and partnerships.

Provider Economics: Discussion on the value proposition for providers joining Privia highlighted improved fee-for-service rates and operational efficiencies, which could enhance growth potential. Overall, Privia Health demonstrated strong operational performance in Q2 2026, with significant growth in key metrics and a positive outlook, despite some concerns regarding payment delays and potential deceleration in growth rates.